Kareo, a medical software provider, and PatientPop, a healthcare marketing business, have joined to produce Tebra, an all-in-one digital platform that helps practises acquire and serve patients, according to the companies. Providers can use Tebra to utilise PatientPop’s services to expand their practise and attract new patients, as well as Kareo’s clinical software for EHR and billing.
- Expansion: Providers can use Tebra to utilise PatientPop’s services to expand their practise and attract new patients, as well as Kareo’s clinical software for EHR and billing. The comprehensive integration of Kareo and PatientPop’s capabilities, according to Travis Schneider, co-CEO and co-founder of PatientPop who will serve as Tebra’s chief business development officer, would help practises succeed in a competitive market.
- Merges: “By bringing the two companies together, we believe we can deliver to the market the first truly all-in-one platform to run a healthcare practice,” said Dan Rodrigues, founder and CEO of Kareo, in an interview with Fierce Healthcare. Rodrigues will serve as the CEO of Tebra. The name Tebra, a derivation of the word “vertebra,” embodies the company’s vision, Rodrigues said—“becoming the digital backbone of practice success.”
- Experience: Rodrigues said patients are demanding a more modern healthcare experience in the digital age, but many practices are unable to meet those expectations on their own “especially in a rapidly changing, competitive environment. One of the challenges that many of these provider organizations face is just how fragmented the vendor landscape is today,” he said. “Many of them are using four or five different products in their practice, they have no in-house IT, and it’s really hard to stitch together a solution that way.”
- Operations: Kareo and PatientPop will continue to operate as independent brands in the near future, with the goal of fully integrating their offerings under the Tebra brand by the end of the first quarter of 2022.With the merger finalized, the new team is already looking toward future product offerings, potentially even a consumer marketplace on top of the Tebra platform, Rodrigues said.
- Capabilities: The company has substantial R&D capabilities internally to develop offerings on its own, he said, but noted that the “very fragmented” market also offers opportunities for future M&A. “What excites us the most is we genuinely feel like we’re building something that’s going to be transformational, and it doesn’t yet exist in the industry,” Schneider said. “And at the end of the day, it’s going to really serve and help the healthcare practices out there, regardless of specialty and size.”
Leave a Reply